Related Experiment Videos

Abnormal myelination in a patient with deletion 14q11.2q13.1

G P Ramelli1, L Remonda, K O Lövblad

  • 1Department of Pediatrics, Ospedale San Giovanni, Bellinzona, Switzerland.

Pediatric Neurology
|October 6, 2000
PubMed

Insights

This study describes the first reported patient with a chromosome 14 deletion and abnormal brain myelination. The deletion, del(14)(q11.2q13), was associated with severe neurological symptoms and developmental abnormalities.

Area of Science:

  • Genetics
  • Neurology
  • Radiology

Background:

  • Interstitial deletions of chromosome 14 are rare genetic events.
  • Abnormal myelination is a significant indicator of neurological dysfunction.
  • Magnetic Resonance Imaging (MRI) is crucial for assessing brain structure and myelination.

Purpose of the Study:

  • To report a novel case of a male patient with an interstitial deletion of chromosome 14.
  • To document and analyze the associated abnormal myelination patterns observed via MRI.
  • To highlight the clinical and radiological features in this unique genetic condition.

Main Methods:

  • Case report of a male patient.
  • Genetic analysis to identify chromosomal deletion (presumed del(14)(q11.2q13)).
  • Magnetic Resonance Imaging (MRI), specifically T(2)-weighted sequences, to evaluate myelination.

Main Results:

  • The patient presented with an interstitial deletion of chromosome 14, del(14)(q11.2q13).
  • Abnormal myelination was identified on T(2)-weighted MRI, showing high-signal intensity.
  • Severe neurologic signs, dysmorphic features, and marked microcephaly were observed.

Conclusions:

  • This represents the first reported case of abnormal myelination in a patient with a chromosome 14 deletion.
  • The findings underscore the potential neurological impact of chromosome 14 deletions.
  • Further research is warranted to understand the specific mechanisms linking this deletion to myelination defects.

Related Concept Videos